These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33968773)

  • 21. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
    Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
    PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice.
    Vucenik I; Zhang ZS; Shamsuddin AM
    Anticancer Res; 1998; 18(6A):4091-6. PubMed ID: 9891450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.
    Liu Z; Wang C; Jiao X; Zhao S; Liu X; Wang Y; Zhang J
    Am J Transl Res; 2016; 8(11):4764-4777. PubMed ID: 27904678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
    Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
    Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral morphine for cancer pain.
    Wiffen PJ; Wee B; Moore RA
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003868. PubMed ID: 27105021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral morphine for cancer pain.
    Wiffen PJ; Wee B; Moore RA
    Cochrane Database Syst Rev; 2013 Jul; (7):CD003868. PubMed ID: 23881654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
    Atorrasagasti C; Malvicini M; Aquino JB; Alaniz L; Garcia M; Bolontrade M; Rizzo M; Podhajcer OL; Mazzolini G
    Int J Cancer; 2010 Jun; 126(11):2726-40. PubMed ID: 19830689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
    Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
    Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect.
    Kim SG; Seo SH; Shin JH; Yang JP; Lee SH; Shin EH
    J Cell Mol Med; 2019 May; 23(5):3234-3245. PubMed ID: 30834688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells.
    Liang BY; Xiong M; Ji GB; Zhang EL; Zhang ZY; Dong KS; Chen XP; Huang ZY
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):535-540. PubMed ID: 26223923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 34. 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
    Deng LJ; Lei YH; Quan JY; Li BJ; Zhang DM; Tian HY; Chen Y; Zhang EX; Chen L; Ye WC; Ning WM; Yu LZ; Liu JS
    J Ethnopharmacol; 2021 Feb; 266():113443. PubMed ID: 33022344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
    Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
    Oncotarget; 2017 Nov; 8(58):97835-97850. PubMed ID: 29228655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral morphine for cancer pain.
    Wiffen PJ; McQuay HJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003868. PubMed ID: 17943804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silibinin efficacy against human hepatocellular carcinoma.
    Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
    Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine: double-faced roles in the regulation of tumor development.
    Zhang XY; Liang YX; Yan Y; Dai Z; Chu HC
    Clin Transl Oncol; 2018 Jul; 20(7):808-814. PubMed ID: 29127594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.